|
Kendle International Inc. - Company Profile Snapshot
| Company Profile: |
Kendle International Inc. |
| Ticker: |
KNDL |
| Exchanges: |
NAS |
| 2008 Sales: |
678,580,000 |
| Major Industry: |
Miscellaneous |
| Sub Industry: |
Medical Services |
| Country: |
UNITED STATES |
| Employees: |
4275 |
Business Description
Kendle International Inc.. The Group's principal activity is to provides Phase I-IV global clinical development services to the biopharmaceutical industry. It operates in two segments: Early Stage and Late Stage. The Early Stage segment focuses on the Group's Phase I operations, the high-end scientific exploratory medicine area. The Late Stage is comprised of clinical development services related to Phases II through IV, includes four reporting units: Global Clinical Development, Late Phase, Regulatory Affairs and Quality and Biometrics. The Global Clinical Development unit conducts Phase II and III clinical trials worldwide. The Late Phase unit designs and conducts Phase IIIB and IV studies worldwide. The Regulatory Affairs and Quality unit provides regulatory expertise and consulting services.The Biometrics unit offers customized clinical data management. It operates in the United States, Europe, Asia Pacific and Africa. In June 2008, it acquired DecisionLine Clinical Research Corporation.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
